NDC 61958-2205

Epclusa

Velpatasvir And Sofosbuvir

Epclusa is a Oral Pellet in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Sofosbuvir; Velpatasvir.

• Product ID: 61958-2205_40f3a9f4-caa0-4d29-8080-1815053c6553
• NDC: 61958-2205
• Product Type: Human Prescription Drug
• Proprietary Name: Epclusa
• Generic Name: Velpatasvir And Sofosbuvir
• Dosage Form: Pellet
• Route of Administration: ORAL
• Marketing Start Date: 2021-06-10
• Marketing Category: NDA /
• Application Number: NDA214187
• Labeler Name: Gilead Sciences, Inc.
• Substance Name: SOFOSBUVIR; VELPATASVIR
• Active Ingredient Strength: 150 mg/1; mg/1
• Pharm Classes: Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 61958-2205-1

28 PACKET in 1 CARTON (61958-2205-1) > 1 PELLET in 1 PACKET

• Marketing Start Date: 2021-06-10
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Epclusa" or generic name "Velpatasvir And Sofosbuvir"

NDC	Brand Name	Generic Name
61958-2201	Epclusa	Velpatasvir and Sofosbuvir
61958-2203	Epclusa	Velpatasvir and Sofosbuvir
61958-2204	Epclusa	Velpatasvir and Sofosbuvir
61958-2205	Epclusa	Velpatasvir and Sofosbuvir
72626-2701	Sofosbuvir and Velpatasvir	Velpatasvir and Sofosbuvir